1. Home
  2. SPTN vs DAWN Comparison

SPTN vs DAWN Comparison

Compare SPTN & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPTN
  • DAWN
  • Stock Information
  • Founded
  • SPTN 1917
  • DAWN 2018
  • Country
  • SPTN United States
  • DAWN United States
  • Employees
  • SPTN N/A
  • DAWN N/A
  • Industry
  • SPTN Food Distributors
  • DAWN Biotechnology: Pharmaceutical Preparations
  • Sector
  • SPTN Consumer Discretionary
  • DAWN Health Care
  • Exchange
  • SPTN Nasdaq
  • DAWN Nasdaq
  • Market Cap
  • SPTN 596.4M
  • DAWN 658.9M
  • IPO Year
  • SPTN N/A
  • DAWN 2021
  • Fundamental
  • Price
  • SPTN $26.54
  • DAWN $6.71
  • Analyst Decision
  • SPTN Hold
  • DAWN Strong Buy
  • Analyst Count
  • SPTN 1
  • DAWN 6
  • Target Price
  • SPTN $26.90
  • DAWN $30.17
  • AVG Volume (30 Days)
  • SPTN 704.9K
  • DAWN 1.3M
  • Earning Date
  • SPTN 08-14-2025
  • DAWN 08-05-2025
  • Dividend Yield
  • SPTN 3.28%
  • DAWN N/A
  • EPS Growth
  • SPTN N/A
  • DAWN N/A
  • EPS
  • SPTN N/A
  • DAWN N/A
  • Revenue
  • SPTN $9,652,685,000.00
  • DAWN $161,922,000.00
  • Revenue This Year
  • SPTN $6.07
  • DAWN $17.98
  • Revenue Next Year
  • SPTN N/A
  • DAWN $49.50
  • P/E Ratio
  • SPTN N/A
  • DAWN N/A
  • Revenue Growth
  • SPTN 0.26
  • DAWN N/A
  • 52 Week Low
  • SPTN $17.30
  • DAWN $6.08
  • 52 Week High
  • SPTN $26.69
  • DAWN $16.76
  • Technical
  • Relative Strength Index (RSI)
  • SPTN 73.98
  • DAWN 47.98
  • Support Level
  • SPTN $26.37
  • DAWN $6.32
  • Resistance Level
  • SPTN $26.63
  • DAWN $7.18
  • Average True Range (ATR)
  • SPTN 0.08
  • DAWN 0.29
  • MACD
  • SPTN -0.26
  • DAWN 0.01
  • Stochastic Oscillator
  • SPTN 26.67
  • DAWN 36.11

About SPTN SpartanNash Company

SpartanNash Co is a food solutions company that delivers the ingredients. Its principal business activities include, distributing grocery products to a diverse group of independent and chain retailers, its corporate-owned retail stores, and U.S. military commissaries and exchanges; as well as operating a fresh produce distribution network and the Our Family private label brand. The company operates in two segments: Retail and Wholesale. Majority of the revenue is earned from its Wholesale segment which uses a multi-channel sales approach to distribute national brand and private brand products to independent retailers, national accounts, food service distributors, e-commerce providers, and the Company's corporate owned retail stores.

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.

Share on Social Networks: